A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07137286
- Status
- Recruiting
Conditions
- LDL Hyper-responsiveness
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed "hyper-responders", have identifiable genetic variations in genes involved in cholesterol absorption.
Key Dates
- Start date
- Sep 11, 2025
- Status verified
- Nov 2025
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Number of Patients to have a genetic mutation [ Time Frame: Baseline ]
Central Contacts
- Saad Omar507-538-5162
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Stephen Kopecky, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site